In the latest randomized trial, in patients with T2D and high cardiovascular (CV) risk, linagliptin showed non-inferiority compared with placebo in the risk of major CV events, with a median time of 2.2 years [72]
This redox imbalance promotes mitochondrial DNA damage, lipid peroxidation, and activation of apoptotic pathways, ultimately contributing to myofibrillar disorganisation and interstitial fibrosis (73)
While some level of gastrointestinal discomfort can occur when taking GLP-1 medications, severe side effects are exceedingly uncommon
These immunomodulatory strategies mean that individual parasites can colonise a host for many years while preventing the development of sterilising protective immunity and suppressing the onset of inappropriate immune responses to innocuous antigens (McSorley et al., 2011
Triple GIP/GLP-1/glucagon receptor co-agonists The success of dual receptor agonists for the treatment of type 2 diabetes and obesity in clinical trials, including the approval of one such drug by the FDA and EMA (currently only for type 2 diabetes), has prompted the search for new combinatorial approaches
Every single batch is independently verified by accredited laboratories to ensure it meets our strict standards for purity, identity, and consistency
